Allergic disorders: When should you consider immunotherapy?

Rana S. Bonds, J. Andrew Grant, William J. Calhoun

Research output: Contribution to journalReview articlepeer-review


Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergsns once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

Original languageEnglish (US)
Pages (from-to)405-412
Number of pages8
Issue number4
StatePublished - Apr 1 2007


  • Allergic asthma
  • Allergic rhinitis
  • Immunotherapy
  • Venom allergy

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Allergic disorders: When should you consider immunotherapy?'. Together they form a unique fingerprint.

Cite this